Should Sell EZCORP After a Director Sells 10,000 Shares
When a EZCORP director unloads 10,000 shares, investors naturally wonder if it signals trouble or simply a routine di...
This intro covers zero-fee index funds available in 2024, helping you compare costs and identify cost-efficient options for long-term investing.
15,443 articlesWhen a EZCORP director unloads 10,000 shares, investors naturally wonder if it signals trouble or simply a routine di...
Venus Protocol launches a controlled test of tokenized stocks as DeFi collateral on BNB Chain, starting with Tesla, N...
Coherent is set to join the S&P 500 on March 23, 2026, triggering automatic purchases by index funds. The move follow...
On July 1, 2026, SOXL tumbled 16% in a single session as its leveraged structure amplified the move. The fallout reve...
Living with bad credit can make debt relief feel out of reach. This guide covers affordable debt relief options for b...
The market is hovering around record levels, but does that mean you should sit on the sidelines? Not necessarily. Thi...
Southeast Asia’s fast-growing hospitality is expanding rapidly, but a persistent labor shortage threatens growth as b...
Kadant is navigating 2025 with a mix of packaging strength and manufacturing headwinds. This guide breaks down what t...
RadNet’s 2025 earnings outlook hinges on imaging volumes, payer dynamics, and cost discipline. This guide breaks down...
The YieldMax TSLA Option Income Strategy ETF drew attention in 2024 for big payouts and a high-yield claim, but its s...
A cliff-like Medicare IRMAA rule makes a tiny annual income step cost retirees hundreds more each month. This report ...
A synthetic covered‑call ETF on MicroStrategy stock continues to pay outs through monthly distributions, yet the stra...